Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

263 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk-taking in schizophrenia and controls with and without cannabis dependence.
Fischer BA, McMahon RP, Kelly DL, Wehring HJ, Meyer WA, Feldman S, Carpenter WT, Gorelick DA. Fischer BA, et al. Among authors: gorelick da. Schizophr Res. 2015 Feb;161(2-3):471-7. doi: 10.1016/j.schres.2014.11.009. Epub 2014 Nov 22. Schizophr Res. 2015. PMID: 25467541 Free PMC article.
Cannabis withdrawal in chronic cannabis users with schizophrenia.
Boggs DL, Kelly DL, Liu F, Linthicum JA, Turner H, Schroeder JR, McMahon RP, Gorelick DA. Boggs DL, et al. Among authors: gorelick da. J Psychiatr Res. 2013 Feb;47(2):240-5. doi: 10.1016/j.jpsychires.2012.10.010. Epub 2012 Nov 10. J Psychiatr Res. 2013. PMID: 23146560 Free PMC article.
Psychiatric symptom differences in people with schizophrenia associated with substantial lifetime substance use but no current substance use disorder.
Koola MM, Gorelick DA, McMahon RP, Liu F, Huestis MA, Linthicum J, Feldman SM, Warren KR, Wehring HJ, Kelly DL. Koola MM, et al. Among authors: gorelick da. Schizophr Res. 2014 Jan;152(1):315-6. doi: 10.1016/j.schres.2013.11.035. Epub 2013 Dec 12. Schizophr Res. 2014. PMID: 24333005 Free PMC article. No abstract available.
Rasagiline in the Treatment of the Persistent Negative Symptoms of Schizophrenia.
Buchanan RW, Weiner E, Kelly DL, Gold JM, Keller WR, Waltz JA, McMahon RP, Gorelick DA. Buchanan RW, et al. Among authors: gorelick da. Schizophr Bull. 2015 Jul;41(4):900-8. doi: 10.1093/schbul/sbu151. Epub 2014 Nov 2. Schizophr Bull. 2015. PMID: 25368372 Free PMC article. Clinical Trial.
Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot study.
Kelly DL, Gorelick DA, Conley RR, Boggs DL, Linthicum J, Liu F, Feldman S, Ball MP, Wehring HJ, McMahon RP, Huestis MA, Heishman SJ, Warren KR, Buchanan RW. Kelly DL, et al. Among authors: gorelick da. J Clin Psychopharmacol. 2011 Feb;31(1):86-91. doi: 10.1097/JCP.0b013e318204825b. J Clin Psychopharmacol. 2011. PMID: 21192149 Free PMC article. Clinical Trial.
Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers.
Levin KH, Copersino ML, Heishman SJ, Liu F, Kelly DL, Boggs DL, Gorelick DA. Levin KH, et al. Among authors: gorelick da. Drug Alcohol Depend. 2010 Sep 1;111(1-2):120-7. doi: 10.1016/j.drugalcdep.2010.04.010. Epub 2010 May 26. Drug Alcohol Depend. 2010. PMID: 20510550 Free PMC article.
Antagonist-elicited cannabis withdrawal in humans.
Gorelick DA, Goodwin RS, Schwilke E, Schwope DM, Darwin WD, Kelly DL, McMahon RP, Liu F, Ortemann-Renon C, Bonnet D, Huestis MA. Gorelick DA, et al. J Clin Psychopharmacol. 2011 Oct;31(5):603-12. doi: 10.1097/JCP.0b013e31822befc1. J Clin Psychopharmacol. 2011. PMID: 21869692 Free PMC article. Clinical Trial.
263 results